Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis

Lopez-Novoa, 2010, The physiological role of endoglin in the cardiovascular system, Am J Physiol Heart Circ Physiol, 299, H959, 10.1152/ajpheart.01251.2009 Bot, 2009, Increased expression of the transforming growth factor-beta signaling pathway, endoglin, and early growth response-1 in stable plaques, Stroke, 40, 439, 10.1161/STROKEAHA.108.522284 St-Jacques, 1994, Molecular characterization and in situ localization of murine endoglin reveal that it is a transforming growth factor-beta binding protein of endothelial and stromal cells, Endocrinology, 134, 2645, 10.1210/en.134.6.2645 Lastres, 1992, Regulated expression on human macrophages of endoglin, an arg-gly-asp-containing surface antigen, Eur J Immunol, 22, 393, 10.1002/eji.1830220216 Tian, 2010, Endothelial cells are activated during hypoxia via endoglin/alk-1/smad1/5 signaling in vivo and in vitro, Biochem Biophys Res Commun, 392, 283, 10.1016/j.bbrc.2009.12.170 ten Dijke, 2008, Endoglin in angiogenesis and vascular diseases, Angiogenesis, 11, 79, 10.1007/s10456-008-9101-9 Piao, 2006, Significant expression of endoglin (cd105), tgfbeta-1 and tgfbeta r-2 in the atherosclerotic aorta: an immunohistological study, J Atheroscler Thromb, 13, 82, 10.5551/jat.13.82 Conley, 2000, Endoglin, a tgf-beta receptor-associated protein, is expressed by smooth muscle cells in human atherosclerotic plaques, Atherosclerosis, 153, 323, 10.1016/S0021-9150(00)00422-6 Nachtigal, 2009, Endoglin co-expression with enos, smad2 and phosphorylated smad2/3 in normocholesterolemic and hypercholesterolemic mice: an immunohistochemical study, Histol Histopathol, 24, 1499 Nachtigal, 2009, Atorvastatin increases endoglin, smad2, phosphorylated smad2/3 and enos expression in apoe/ldlr double knockout mice, J Atheroscler Thromb, 16, 265, 10.5551/jat.E745 Powers, 2010, Soluble fms-like tyrosine kinase 1 (sflt1), endoglin and placental growth factor (plgf) in preeclampsia among high risk pregnancies, PLoS One, 5, e13263, 10.1371/journal.pone.0013263 Levine, 2006, Soluble endoglin and other circulating antiangiogenic factors in preeclampsia, N Engl J Med, 355, 992, 10.1056/NEJMoa055352 Blazquez-Medela, 2010, Increased plasma soluble endoglin levels as an indicator of cardiovascular alterations in hypertensive and diabetic patients, BMC Med, 8, 86, 10.1186/1741-7015-8-86 Blanco, 2005, Interaction and functional interplay between endoglin and alk-1, two components of the endothelial transforming growth factor-beta receptor complex, J Cell Physiol, 204, 574, 10.1002/jcp.20311 Yao, 2007, Activin-like kinase receptor 1 (alk1) in atherosclerotic lesions and vascular mesenchymal cells, Cardiovasc Res, 74, 279, 10.1016/j.cardiores.2006.09.014 Yao, 2008, High-density lipoproteins affect endothelial bmp-signaling by modulating expression of the activin-like kinase receptor 1 and 2, Arterioscler Thromb Vasc Biol, 28, 2266, 10.1161/ATVBAHA.108.176958 Tassone, 2011, Antidepressant hyperforin up-regulates vegf in cns tumour cells, Pharmacol Res, 63, 37, 10.1016/j.phrs.2010.09.005 Holm, 2009, Atherosclerotic plaque development and instability: a dual role for vegf, Ann Med, 41, 257, 10.1080/07853890802516507 Walshe, 2009, Inhibition of vegf or tgf-β signaling activates endothelium and increases leukocyte rolling, Arterioscler Thromb Vasc Biol, 29, 1185, 10.1161/ATVBAHA.109.186742 Zhou, 2010, Pleiotropic effects of statins—basic research and clinical perspectives, Circ J, 74, 818, 10.1253/circj.CJ-10-0110 Aydin, 2009, Effects of atorvastatin therapy on protein oxidation and oxidative DNA damage in hypercholesterolemic rabbits, Pharmacol Res, 59, 242, 10.1016/j.phrs.2009.01.004 Zadelaar, 2007, Mouse models for atherosclerosis and pharmaceutical modifiers, Arterioscler Thromb Vasc Biol, 27, 1706, 10.1161/ATVBAHA.107.142570 Nachtigal, 2004, Application of stereological methods for the quantification of vcam-1 and icam-1 expression in early stages of rabbit atherogenesis, Pathol Res Pract, 200, 219, 10.1016/j.prp.2004.02.008 Brcakova, 2009, Alteration of methotrexate biliary and renal elimination during extrahepatic and intrahepatic cholestasis in rats, Biol Pharm Bull, 32, 1978, 10.1248/bpb.32.1978 Ma, 2000, Endoglin is overexpressed after arterial injury and is required for transforming growth factor-beta-induced inhibition of smooth muscle cell migration, Arterioscler Thromb Vasc Biol, 20, 2546, 10.1161/01.ATV.20.12.2546 Eussen, 2011, Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in ldlr-/-mice, Pharmacol Res, 10.1016/j.phrs.2011.02.008 Santibanez, 2007, Endoglin increases enos expression by modulating smad2 protein levels and smad2-dependent tgf-beta signaling, J Cell Physiol, 210, 456, 10.1002/jcp.20878 Blaha, 2008, Elevated serum soluble endoglin (scd105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia, Atherosclerosis, 197, 264, 10.1016/j.atherosclerosis.2007.04.022 De Vivo, 2008, Endoglin, plgf and sflt-1 as markers for predicting pre-eclampsia, Acta Obstet Gynecol Scand, 87, 837, 10.1080/00016340802253759 Perez-Gomez, 2010, The role of the tgf-beta coreceptor endoglin in cancer, ScientificWorldJournal, 10, 2367, 10.1100/tsw.2010.230 Ley, 2001, Vcam-1 is critical in atherosclerosis, J Clin Invest, 107, 1209, 10.1172/JCI13005 Cybulsky, 2001, A major role for vcam-1, but not icam-1, in early atherosclerosis, J Clin Invest, 107, 1255, 10.1172/JCI11871 Ramos, 1999, Direct demonstration of p-selectin- and vcam-1-dependent mononuclear cell rolling in early atherosclerotic lesions of apolipoprotein e-deficient mice, Circ Res, 84, 1237, 10.1161/01.RES.84.11.1237 Utsumi, 2007, Effects of selective ldl apheresis on plasma concentrations of icam-1, vcam-1 and p-selectin in diabetic patients with arteriosclerosis obliterans and receiving maintenance hemodialysis, Clin Chim Acta, 377, 198, 10.1016/j.cca.2006.09.026 Hajilooi, 2004, Circulating icam-1, vcam-1, e-selectin, p-selectin, and tnfrii in patients with coronary artery disease, Immunol Invest, 33, 263, 10.1081/IMM-120037275 Luc, 2003, Circulating soluble adhesion molecules icam-1 and vcam-1 and incident coronary heart disease: the prime study, Atherosclerosis, 170, 169, 10.1016/S0021-9150(03)00280-6 Demerath, 2001, The relationship of soluble icam-1, vcam-1, p-selectin and e-selectin to cardiovascular disease risk factors in healthy men and women, Ann Hum Biol, 28, 664, 10.1080/03014460110048530 Venkatesha, 2006, Soluble endoglin contributes to the pathogenesis of preeclampsia, Nat Med, 12, 642, 10.1038/nm1429 Lopez-Novoa, 2007, Soluble endoglin is an accurate predictor and a pathogenic molecule in pre-eclampsia, Nephrol Dial Transplant, 22, 712, 10.1093/ndt/gfl768 Bourdeau, 2000, Endoglin-deficient mice, a unique model to study hereditary hemorrhagic telangiectasia, Trends Cardiovasc Med, 10, 279, 10.1016/S1050-1738(01)00062-7 Hawinkels, 2010, Matrix metalloproteinase-14 (mt1-mmp)-mediated endoglin shedding inhibits tumor angiogenesis, Cancer Res, 70, 4141, 10.1158/0008-5472.CAN-09-4466